The progression of pulmonary arterial hypertension induced by monocrotaline is characterized by lung nitrosative and oxidative stress, and impaired pulmonary artery reactivity

Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective

(2020) Thomas Koudstaal et al.   Journal of Clinical Medicine

Evaluation and classification of pulmonary arterial hypertension

(2019) Sandeep Sahay   Journal of Thoracic Disease

Pharmacotherapy for pulmonary arterial hypertension

(2019) Vishal Parikh et al.   Journal of Thoracic Disease

ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial Hypertension

(2018) Grant R. Budas et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Bucindolol attenuates the vascular remodeling of pulmonary arteries by modulating the expression of the endothelin-1 A receptor in rats with pulmonary arterial hypertension

(2018) Bruna Gazzi de Lima-Seolin et al.   BIOMEDICINE & PHARMACOTHERAPY

Cathepsin B inhibition attenuates cardiovascular pathology in mucopolysaccharidosis I mice

(2018) Esteban Alberto Gonzalez et al.   LIFE SCIENCES

IL-33 Initiates Vascular Remodelling in Hypoxic Pulmonary Hypertension by up-Regulating HIF-1α and VEGF Expression in Vascular Endothelial Cells

(2018) Jie Liu et al.   EBioMedicine

Effects of aerobic exercise training on metabolism of nitric oxide and endothelin-1 in lung parenchyma of rats with pulmonary arterial hypertension

(2017) A. Zimmer et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Rapamycin reduced pulmonary vascular remodelling by inhibiting cell proliferation via Akt/mTOR signalling pathway down-regulation in the carotid artery–jugular vein shunt pulmonary hypertension rat model

(2017) Xiaofan Ma et al.   Interactive Cardiovascular and Thoracic Surgery

World Health Organization Group I Pulmonary Hypertension

(2016) Kurt W. Prins et al.   CARDIOLOGY CLINICS

Selective activation of angiotensin AT2receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis

(2015) E Bruce et al.   BRITISH JOURNAL OF PHARMACOLOGY

Melatonin as a preventive and curative therapy against pulmonary hypertension

(2015) Gerald Maarman et al.   JOURNAL OF PINEAL RESEARCH

Exploring the monocrotaline animal model for the study of pulmonary arterial hypertension: A network approach

(2015) Rita Nogueira-Ferreira et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Chronic intrauterine pulmonary hypertension increases main pulmonary artery stiffness and adventitial remodeling in fetal sheep

(2014) R. Blair Dodson et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Pulmonary Arterial Hypertension

(2014) Yen-Chun Lai et al.   CIRCULATION RESEARCH

Left and Right Ventricle Late Remodeling Following Myocardial Infarction in Rats

(2013) Ivanita Stefanon et al.   PLoS One

Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension

(2012) Helen Christou et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Modern Age Pathology of Pulmonary Arterial Hypertension

(2012) Elvira Stacher et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Matrix metalloproteinases and their inhibitors in pulmonary hypertension

(2012) Prakash Chelladurai et al.   EUROPEAN RESPIRATORY JOURNAL

RV Dysfunction In Pulmonary Hypertension Is Independently Related To Pulmonary Artery Stiffness

(2012) Gerin R. Stevens et al.   JACC-Cardiovascular Imaging

Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling

(2011) Jisun Lee et al.   BIOCHEMICAL JOURNAL

A comparison of echocardiography to invasive measurement in the evaluation of pulmonary arterial hypertension in a rat model

(2010) Juha W. Koskenvuo et al.   INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING

Modulation of Monocrotaline-Induced Cor Pulmonale by Grape Juice

(2010) Ana R L Ludke et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration

(2009) You-Yang Zhao et al.   JOURNAL OF CLINICAL INVESTIGATION

Impaired Vasoconstriction and Nitric Oxide-Mediated Relaxation in Pulmonary Arteries of Hypoxia- and Monocrotaline-Induced Pulmonary Hypertensive Rats

(2009) V. Mam et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Effects of endogenous sulfur dioxide on monocrotaline-induced pulmonary hypertension in rats1

(2008) Hong-fang JIN et al.   ACTA PHARMACOLOGICA SINICA